INTRODUCTION
Activation of cell-surface receptors by appropriate ligands causes the generation of second messengers which are released in the cell interior. Such transmembrane signalling mechanisms pervade the whole of biology and the classic example is that of cyclic AMP produced as a result of an increase in the activity of an integral membrane enzyme, adenylate cyclase. In this case, receptor stimulation results in the association of the activated receptor with a GTP-binding protein, G., and this, in turn, regulates the activity of adenylate cyclase. The minimum requirement for this signalling cascade is three proteins residing in a single compartment, the plasma membrane with the cytosolic compartment providing the substrate, MgATP for adenylate cyclase.
A more recently recognized transmembrane signalling system is the cascade that regulates intracellular Ca2l and protein phosphorylation. This remarkable system where hydrolysis of a phospholipid results in the generation of two second messengers has captured the imagination of many people working in disparate areas such as cell growth and differentiation, plant physiology, phototransduction in invertebrates, and a host of functional responses including contraction, secretion, metabolic responses. In many cases, the inositide signalling pathway is the major controller of subsequent events.
The enzyme(s) responsible for hydrolysing the inositol lipid, phosphatidylinositol bisphosphate (PtdInsP2) is a phosphodiesterase of the phospholipase C type. By this we mean that this enzyme is responsible for rupturing the bond between the oxygen and the phosphate such that the products of the reaction are diacylglycerol and the water-soluble headgroup, Ins(1,4,5)P3. Diacylglycerol is responsible for activating a large family of protein kinase C isoenzymes, which catalyse protein phosphorylation. InsP3 on the other hand interacts with a receptor on the endoplasmic recticulum to release Ca2+ from internal stores. This simultaneous generation of two second messengers sets in motion a train of events that results in the culmination of the cellular response. The number of receptors that use this signalling pathway is extensive and what has now emerged is that phospholipase C is regulated by receptors by at least two distinct pathways. The presence of multiple isoforms of PLC which bear minimal relationship was already a clear indication that differential regulation may occur. Two pathways that have been clearly and unambiguously identified are G-protein-mediated and tyrosine kinase-mediated regulation of PLCs.
In this Review we focus on the different isoforms that constitute the phospholipase C family. Several reviews have appeared recently on the enzymology of phospholipase C (see [1] [2] [3] [4] [5] [6] [7] ) and therefore this review focuses on the recent explosion in our knowledge regarding the regulation of the phospholipases by receptors. For this reason, a number of reconstitution systems have been developed to address this problem. The advantages of different reconstitution systems and their drawbacks will be discussed.
LOCALIZATION OF PLC ISOENZYMES: CYTOSOLIC VERSUS MEMBRANE-ASSOCIATED
Early studies on phospholipase C had clearly established that this enzyme was predominantly resident in the cytosol [8] although a case for a membrane location had also been made [9] [10] [11] [12] . Membrane localization of PLC had been a source of controversy in the past [13] . The concept that the inositol lipids may be a source of second messengers goes back to the 1970s [14] , and it was hypothesized that for phospholipase C to play a role in cellular signalling, the enzyme had to be located at the plasma membrane, by analogy with adenylate cyclase.
More recently, the majority of the phospholipases have been purified from the cytosolic fraction [15] [16] [17] [18] [19] [20] [21] . Although the activity is present mostly in the cytosolic fraction when the cells are disrupted, a membrane-associated localization of PLCs in the living cell cannot be excluded. Moreover, activity associated with the membranes has also been characterized [22] [23] [24] [25] . Membraneassociated activity can generally be removed by high salt, indicating that it is ionic interactions that attach the PLC to the membranes. Indeed, one ofthe membrane-bound activities 81) is distributed equally between the cytosolic compartment and the membrane compartment [25] . From the hydropathy analysis and amino acid sequence of PLC-,81, there is no indication of the presence oftransmembrane spanning domains. In contrast, PLCyl is found predominantly in the cytosol [25] .
The existence of multiple isoforms of PLC was described very early on in studies of many different tissues including heart, brain, platelets, liver and kidney [26] [27] [28] [29] . Purification of phospholipases C began in earnest when it was recognized that InsP3 and diacylglycerol both function as second messengers (reviewed in [30] ). This finally led to the purification, sequencing and cloning of the multiple isoforms of the phospholipases. The sequence homology between the isoenzymes was found to be limited.
Another approach that has provided a useful means to tackle the problem of localization of PLCs in living cells is cell permeabilization. There are many techniques available that allow selective permeabilization of the plasma membrane of cells while maintaining the intracellular architecture and their ability to respond to appropriate effectors. For the study of large protein molecules, permeabilization techniques that make pores allowing entry of macromolecules > 10 nm are necessary. Streptolysin 0, a bacterial cytolysin, is a very effective tool for generating such pores. Loss of cytosolic proteins such as lactate dehydrogenase (142 kDa) , actin (43 kDa) and phosphoglycerate kinase (40 kDa) Abbreviations used: PLC, phosphoinositide-specific phospholipase C; PtdEtn, phosphatidylethanolamine; GTPyS, guanosine 5'-[ythioltriphosphate; PMA, phorbol myristate acetate; PDGF, platelet-derived growth factor; NGF, nerve growth factor; EGF, epidermal growth factor; TSH, thyrotropin; LH, lutrotropin; PTH, parathyroid hormone; PAF, platelet activating factor; FGF, fibroblast growth factor; IGF, insulin-like growth factor.
Vol. 288 I have been monitored from various cell types, e.g. mast cells and HL60 cells [31] [32] [33] [34] . Following addition of streptolysin 0 to intact cells, the release of cytosol marker enzymes commences within 30 s, and by 5 min the release of cytosolic components is complete [33, 34] . From this it can be inferred that it takes 5 min for truly cytosolic components to diffuse out of the cell. Since diffusion is governed by the size of the molecule, smaller molecules such as ATP or GTPyS equilibrate faster than larger components such as lactate dehydrogenase [35] . PLC isoenzymes have differing molecular sizes, ranging from 70 to 88 kDa and 145 to 155 kDa (see Table 1 ). What happens to PLC when streptolysin 0 is added to cells? PLC also diffuses out of the cells but 20 min is required for maximal loss, which is slower in comparison to the loss of lactate dehydrogenase [36] . This would imply that the distribution of some PLC isoforms is not limited to the cytoplasmic compartment and is possibly in dynamic equilibrium with cell membranes. Permeabilization disturbs this equilibrium such that the majority of the enzyme(s) finally leaves the cell. Stated differently, in living cells a proportion of the phospholipases are likely to be membrane-associated.
There is now strong evidence that phospholipase C may be associated with the nucleus [37, 38] . In Swiss 3T3 cells, it has been shown that PLC-,/1 localized at the nucleus was regulated by IGF-I and is presumably responsible for the known metabolism of inositol lipids at this site [39] . Table 1 provides a classification of the currently identified phospholipases C. In the top section, (a), the classification is based on sequence homology and it only includes those enzymes that can be classified based on the deduced amino acid sequence from their cloned cDNA. Three families of phospholipase C have been identified, /3, y and 6. Within each family, there are several subtypes; subtypes are designated by adding Arabic numerals after the Greek letters as in PLC-/I and PLC-/32, for example [7] . In the lower section, (b), of [6] . The two domains are about 60% and 40% identical respectively. These regions might constitute, separately or jointly, the catalytic domain. The PLC-y isoform has been found to contain the src homology domains, SH2 and SH3. These domains govern protein-protein interactions; the SH2 domain targets the molecule to tyrosine phosphorylated sequences present in other proteins (e.g. the PDGF receptor) and the SH3 domain targets it to cytoskeletal components. These domains are found in a large number of unrelated proteins such as GTPase activating protein (GAP), Ptdlns 3-kinase, tyrosine phosphatases and kinases (see [40] for review).
CLASSIFICATION OF ISOFORMS OF PHOSPHOLIPASES C
The PLC-fl family The PLC-,f family contains three members, PLC-/ll, -,/2 and -,/3, all present in mammalian cells. Tissue distribution of PLC-/3l indicates that it is expressed at different levels in various cell types [6] . For example, in brain it is present in significant amounts but is present in low abundance in other cells, e.g. HL60, a promyelocytic cell line that can be induced to differentiate towards a granulocyte [6] . Presumably other members of the family are present at significantly higher levels in some cells. Our knowledge of the extent of the , family comes indirectly from cDNA analysis rather than from studies of the enzymes themselves. The PLC-y family PLC-y comprises yl and y2, and both forms have been purified (see Table 1 ). A detailed comparison has yet to be undertaken with regard to their biochemical characterization. They are differentially expressed in cells. PLC-y2 isoforms predominate in spleen, B-cells, HL60 cells and lung, whereas PLC-yl is widely distributed in many tissues.
The PLC-6 family and its biochemical comparison to the PLC-e family The PLC-6 family contains three members, 61, 82 and 63. [19] e ? Human platelets [191] a family oc 70 Rat liver cytosol [192, 193] a 65 Seminal vesicular gland [190] a 70 Murine thymocyte cytosol [194, 195] a 70 Murine thymocyte membrane [195] a 62 Guinea pig uterus cytosol [17] oc 61 Human platelet membranes [22] a 57 Bovine brain cytosol [196] a 58 Vascular smooth muscle [197] 6, including the absence of the X and Y domains (see Fig.  1 ). Indeed, it has been suggested that the cDNA clone of PLCa may encode a previously uncharacterized lumenal endoplasmic reticulum protein [43] . A 58 kDa protein that showed near sequence identity with PLC-a sequence was purified from liver microsomes [43] . The is a family of PLCs with a molecular mass of 57-70 kDa which have been purified from a variety of cells (see Table 1 ). It remains possible that they may be proteolytic fragments derived from PLC-,f, -y, and -d types [7] .
Miscellaneous phospholipases
An 18 kDa phospholipase C has been purified from human spleen membranes which seems to be associated with a regulatory component by ionic interactions. When purified as a complex of 60-70 kDa, it has very little PLC activity but on dissociation, PLC activity is enhanced [44] . This provides a novel form of regulation, i.e. dissociation of an inhibitory component to obtain catalytic activity. Clearly, further work is required to characterize this enzyme and its distribution in other tissues.
REGULATION OF PHOSPHOLIPASE C ISOFORMS
The regulation of phospholipase C is distinct for two of the known phospholipase families, PLC-,l and PLC-y (Figs. 2 and 3). PLC-,8 is regulated by G-proteins whilst PLC-yl and y2 are regulated by tyrosine kinases. In addition to PLC-f1, a second PLC designated PLC-c has also been found to be under control by G-proteins. Another important regulator of PLC that has been recognized for a long time is Ca2+ and yet there is very little information regarding which isoforms are Ca2+-regulated.
Various techniques have been used to analyse PLC regulation and, in particular, to address the problems inherent in studying an enzyme whose substrate normally resides in a membrane. Two approaches have been used to study the regulation of PLCs with their potential activators in cell-free preparations.
In the first approach, purified PLCs and their activators are incubated with lipid substrates presented either as mixed micelles or liposomes or as pure substrate, often in the presence of detergents. The main advantage of this system is its simplicity and the individual proteins that are added are clearly identified.
Irvine et al. (1984) demonstrated that presentation of PtdInsP2 in a non-bilayer configuration in the presence of excess PtdEtn enabled its hydrolysis by soluble brain PLC activity at physiological Ca2+ and Mg2+ concentrations [45, 46] . In other words, the enzymes are constitutively active when assayed under conditions where the substrate is presented in a non-bilayer configuration. Therefore assay conditions have to be selected to suppress the catalytic activity so that potential activators can then be tested. The major limitation of this procedure is that the environment in which the enzyme is functioning is totally artificial. In such an assay system, phosphorylated versus non-phosphorylated PLCs do not always show a difference in activity and yet in cells the state of phosphorylation may control PLC activity, e.g. of PLCyl and y2.
The second approach is to use the native cell membranes as opposed to mixed micelles or pure substrate as a source of substrate and purified PLCs are then added back. Under these conditions, the PLCs cannot hydrolyse their substrate. The situation is more analogous to that of an intact cell. Since in cells the PLC will be presented to its lipid substrate, PtdInsP2, in a membrane, this method mimics closely the events occurring in a cell. This approach has the added advantage that receptors will also be present. Also, because the normal complement of Gproteins will be present in the membrane preparation, one is examining interactions between G-proteins and PLC that are physiologically relevant. One drawback with this approach is that the membrane preparation can be the source of the activator, e.g. the G-protein and therefore its identity may not be unambiguously assigned. However, identification of the relevant G-proteins that interact with the PLC can be assessed using antibodies against G-proteins and has already been successfully used [47, 48] . A further extension of this method is the use of membranes from cells which have been transfected with cDNA encoding different G-proteins [49] . In the case of the PLC-yl and y2, the use of native membranes would also permit the question of whether tyrosine phosphorylation actually activates the enzyme in vivo to be asked. This has yet to be established.
G-protein regulation in PLC-pIl and PLC-e isoforms
The involvement of a regulatory G protein termed GP, in the signal transduction mechanism of agonists stimulating the hydrolysis of PtdInsP2 has been strongly implicated for some time.
The main evidence for a G-protein involvement in PLC activation by receptors can be summarized as follows: (a) non-hydrolysable analogues of guanine nucleotides and aluminium fluoride cause increased hydrolysis of endogenous PtdInsP2, (b) GTP is essential for agonist-stimulated PLC activation, and (c) in some cell types, pertussis toxin inhibits PLC activation (reviewed in [50] ). Progress in the identification of the G-proteins became possible when exogenously added PtdInsP2 could be used as a substrate.
Studies with exogenous substrate-the deductive approach. The initial studies utilized exogenous substrates and cytosolic PLC to study G-protein-mediated regulation. The result of these studies were contradictory. For, example, early reports had demonstrated that a cytosolic PLC from platelets, brain, thymocytes and HL60 cells could be activated by guanine nucleotides [51] [52] [53] [54] . Baldassare et al. identified a 29 kDa GTPbinding protein [53] . On the other hand, Rock & Jackowski demonstrated that, in a different assay system, platelet soluble PLC activity is non-specifically stimulated by several nucleotides [55, 56] . In a recent study, the GTPyS-binding activity associated with cytosolic PLC from the platelet cytosol was purified and was identified as an actin-gelsolin (1: 1) complex [57] . One of the obvious lessons emerging is that all effects of GTPyS may not always be mediated by G-proteins.
Other studies in which labelled PtdInsP2 was added to membrane preparations showed that it could be hydrolysed as a consequence of activation of a membrane-bound PLC by either GTPyS or receptor-directed agonists. Such agonist-and guanine nucleotide-dependent stimulation of PLC activity has been observed in membranes from blowfly salivary glands [58, 59] , smooth muscle [60] [61] [62] , fibroblasts [63] , brain [64] [65] [66] [67] [68] [69] , squid photoreceptor [70] , kidney cells (MCDK) [71] and liver [72] . This approach is not universally applicable. In many of the studies addition of detergent was necessary [68, 69] . The incubation conditions used in these diverse studies varied; e.g. substrate presentation, inclusion of detergent and the buffer used in the assay. Conditions of the assay played a crucial role in obtaining activation of the PLC via a G-protein since other studies showed non-specific effects of nucleotides [73] .
Using the liver system, Exton and his colleagues successfully exploited the above assay procedure to purify the G-protein present in the membrane responsible for activating the PLC [72] . The liver membranes provided both the G-protein and the phospholipase C. The assay could be used even when both the PLC and the G-proteins were released from the membranes by sodium cholate. The critical step here was to activate the Gproteins with GTPyS prior to cholate extraction. A 42 kDa PLC activator, immunologically identified as a G-protein x subunit and shown to belong to the Gq class of G-proteins, was found to be the activator [74] . In this in vitro reconstitution assay, the molar ratio of G-protein to PLC is 20: 1 for maximal activation [75] . The Identity of G-proteins that regulate phospholipases C. Clearly the use of exogenous substrate has opened the way to identify the G-proteins that regulate PLC. The Gq family of G-proteins were also purified by Sternweis and his colleagues independently [76] and shown to reconstitute with an enriched preparation of phospholipase C-fll [77] using an in vitro assay method. The partial amino acid sequence was identical to that encoded by a cDNA designated a, [78] [79] [80] . The Gq family comprises at least five G-proteins, Gq, Gll, G14, G15 and G16 [80] . Gq and Gil, which are 88 % identical, are capable ofactivating PLC [49, 81, 82] . These two G-proteins are widely expressed [78, 83, 84] and can selectively activate PLC-,l but not PLC-yl or PLC-81 [75] . G14, G15 and G16 are expressed in a tissue-restricted fashion. G1. and G16 are specifically expressed in cells of the haematopoietic lineage [83, 85] together with PLC-,2 [2] . GaZq purified from a flyaffinity gel was found to stimulate PLC-fl but not PLC-p2 [7, 273] Vol. 288 and indeed it was found that Ga16 (and less effectively, Gaq, Gall, Gacz4) when expressed in Cos-7 cells was most effective in reconstituting with PLC-,82 [7, 274] . That different members of the Gq family activate PLC-,8 isoforms selectively provides ample room for subtle differences in activation characteristics. The mix and match approach of G-proteins and PLCs provides a system which is extremely versatile and can be easily tailored to the requirement of any particular cell. Table 2 lists the receptors and cell types where the effect of pertussis toxin pretreatment on PLC activation has been examined. Pertussis toxin ADP-ribosylates a cysteine residue four amino acids from the C-terminus of G-proteins. This modification of the G-protein impairs its ability to communicate with the appropriate receptor. G-proteins, G,-l, G, 2, G13, Go and transducin all possess the cysteine residue and are therefore substrates for pertussis toxin. Thus pertussis toxin-sensitivity provides an important clue as to the nature of the G-protein.
Cell types fall into three different categories (Table 2 ). In the 5 %2299 [86] or after purification of the PLC from platelet membranes [87] . Two forms of Go, GOA and GOB, when injected into Xenopus oocytes are also able to specifically increase muscarinic receptor stimulation of phospholipase C [88] .
Several important messages are implicit in Table 2 Since the majority of PLC is present in the cytosol, it is possible to remove cytosolic components from cells by permeabilization, leaving a leaky 'ghost' preparation where the membrane compartments remain intact. This 'ghost' preparation has been used for reconstitution [36] . Ghost preparations of red cells (avian) can also be made by hypotonic lysis and have also been used for reconstitution successfully [90] . G-proteins, receptors and the machinery for synthesizing the polyphosphoinositides all remain intact and the 'ghost' preparation is therefore ideal for the study of G-protein-mediated coupling to specific phospholipases [36, 90] .
A 150 kDa PLC purified from turkey eythrocytes [91] has been added back to turkey red cell 'ghosts' and the purified enzyme was able to hydrolyse the endogenous substrate when the purinergic receptor was stimulated [90] . This reconstitution method does not have to be restricted to using PLC and Gprotein from the same source, i.e. homologous reconstitution. A heterologous system has also been used where the membranes were from one source and the enzyme from another. HL60
'.ghost' cells have been reconstituted with PLC-,/1 and with PLCc, both prepared from rat brain cytosol [36] . Although, the Gproteins that are responsible for reconstitution have not been identified, it is known that HL60 cells contain G-proteins of the Gq family as well as G12/3. Identification of the G-proteins that reconstitute with these two enzymes in this experimental situation should provide a good indicator about selectivity of interactions. Clearly, this approach of reconstitution where the normal complement of G-proteins is already present in the membranes will make an important contribution towards understanding which phospholipases associate with which G-proteins under near physiological conditions. This approach essentially complements the in vitro reconstitution system.
Regulation of PLC-y by tyrosine phosphorylation
The regulation of PLC-y family by tyrosine phosphorylation has been reviewed [5] . The first indication that tyrosine phosphorylation may regulate phospholipase C activity came from the published sequence of phospholipase C-yr [92] . The predicted amino acid sequence for the phospholipase C derived from complementary DNA cloning revealed that it possessed regions homologous to the products of various tyrosine kinaserelated oncogenes (yes, src, fgr, abi, fps, fes, tck and crk) [92] [93] [94] . The next significant finding in this story was the demonstration that PLC-yI was a substrate for receptor protein-tyrosine kinases.
Both EGF and PDGF receptors when activated could phosphorylate PLC-yr on tyrosine and serine residues both in vivo and in vitro [95] [96] [97] [98] . By virtue of being phosphorylated on tyrosine residues, phosphotyrosine antibodies immunoprecipitated PLC-yr from EGF-activated A-431 cells [99] . A physical association of PLC-yI with the PDGF and EGF receptor was also demonstrated [100, 101] .
Other receptors with tyrosine kinase activity (e.g. insulin, CSF-1) fail to phosphorylate PLC-y1, indicating that all receptors that are tyrosine kinases are not necessarily able to target PLCy1 as a substrate [101, 102] . The stimulation of PLC appears to require the intrinsic activity of the receptors because mutant PDGF and EGF receptors that lack tyrosine kinase activity bind the growth factors but fail to stimulate the hydrolysis of inositol phospholipids [103, 104] . Phosphorylation at tyrosine residues leads to the activation of PLC-yr [105] . Dephosphorylation by tyrosine phosphatases (48 kDA T cell protein tyrosine phosphatase but not CD45), on the other hand, diminishes the activity of PLC-yr immunoprecipitated from EGF-treated cells [105] .
In the early studies on [110] . However, mutation at residues 771, 783 and 1254 does not change the catalytic activity of PLC-y measured in vitro [110] .
In unstimulated cells, PLC-y is normally found in the cytosolic fraction after cell disruption. On activation by PDGF and EGF, a translocation from the cytosol to the membrane is observed [111, 112] . The mechanism of translocation relies on the affinity of the phosphorylated tyrosine residues on the receptor for the SH2 domains of the PLC-yl. This association permits the phosphorylation of PLC-yl tyrosine residues. Clearly, the association of PLC-yl with the membrane is a key step to enzyme activation.
Regulation of PLC-y2. PLC-y2 appears to be present in abundance in haematopoietic cells [113] [114] [115] . It [118] , neuronal cells in the guinea pig ileum longitudinal smooth muscle [119] , and pancreatic islets [120] . Studies [121] . Ca2+ has also been shown to induce the hydrolysis of PtdInsP2 in human sperm [122] . The [123] , 3T3 cells [124] as well as a human leukaemic T cell line, Jurkat [125, 126] . Intact cells when treated with forskolin, dibutryl cyclic AMP or cholera toxin all exhibit enhanced phosphorylation of PLC-yl. Moreover, the enzyme can also be phosphorylated by cyclic AMPdependent protein kinase in vitro. Prior treatment with agents that increased cyclic AMP levels inhibited the subsequent stimulation of PLC by noradrenaline in rat glioma [123] and by CD3 in Jurkat cells [125] respectively. However, phosphorylation of the enzyme did not lead to any changes in enzyme activity when assessed in vitro [124, 125] indicating that phosphorylation alters interaction of PLC-yl with protein tyrosine kinase or the protein tyrosine phosphatase. This altered interaction may account for the decreased tyrosine phosphorylation of PLC-yl seen in cells where cyclic AMP levels were elevated [126] .
PLC-yl can also by negatively modulated by protein kinase C. Treatment of Jurkat cells with PMA leads to phosphorylation of PLC-yl at Ser-1248, the same residue also phosphorylated by cyclic AMP-dependent kinase. This prior phosphorylation does not permit the tyrosine phosphorylation of PLC-yl to occur, thereby leading to inhibition of CD3-stimulated PLC-yl activation. Clearly, a prior protein phosphorylation by either protein kinase A or protein kinase C diminishes the ability for PLC-y1 to be phosphorylated on tyrosine residues, hence leading to inhibition [126] . Protein kinase C-dependent inhibition of PLC-yl is not always observed [127, 128] .
PLC-,81 is phosphorylated by protein kinase C but not by protein kinase A. Treatment of PC 12, C6Bul and NIH 3T3 cells with PMA stimulated the phosphorylation of serine residues (Ser-887) in PLC-,81 but not PLC-81 or PLC-yl [127] . (PLC-yl phosphorylated by protein kinase C in Jurkat cells may be an exception [126] .) Phosphorylation of pure PLC-fl by protein kinase C in vitro also results in a stochiometric incorporation of phosphate at a single serine residue (Ser-887) [127] . The catalytic activity in an assay in vitro is not affected by phosphorylation of PLC-,81 by protein kinase C [127] . The experiment that has yet to be done is to test the ability of the phosphorylated versus the unphosphorylated PLC-fl enzyme both in the in vitro reconstitution system with purified Gq as well as in the permeabilized HL60 system. This may reveal whether the phosphorylation of PLC fll has any effect on its function.
RECEPTORS THAT ACTIVATE PHOSPHOLIPASES C CAN BE CATEGORIZED BY THE MODE OF PLC ACTIVATION: G-PROTEINS VERSUS TYROSINE KINASE-DEPENDENT PHOSPHORYLATION G-protein-coupled receptors
The G-protein-coupled receptors so far identified show differential pertussis toxin sensitivity (Table 2) . Two phospholipases (PLC-fl and PLC-c) have been identified that can be Gprotein-regulated. In Table 3 , we have summarized some of the receptor systems that are now known to be coupled to either specific G-proteins and/or PLC. What emerges very clearly is that the Gq family of G-proteins regulate the PLC-,81 family and this accounts for the large proportion of the pertussis toxifinsensitive G-protein regulated PLC activity. This relationship also holds for the invertebrate system (see below).
Receptors that are intrinsic tyrosine kinases or regulate cytosolic tyrosine kinases Many receptors are intrinsic tyrosine kinases, such as PDGF and EGF. These receptors appear to recruit the PLC-yl isoform of PLC. This is summarized in Table 4 . Many other receptors have been identified that regulate cytosolic tyrosine kinases and increasing evidence suggests that many of these receptors also active PLC-yl by tyrosine phosphorylation. These receptors are summarized in Table 4 and are discussed individually below. The ability to recognize and respond to foreign antigen is fundamental to the function of the cells of the immune system. [133, 134] .
Direct evidence for tyrosine phosphorylation of PLC-yl via the T cell receptor has now been presented [125, [135] [136] [137] . PLCyl phosphorylation on both serine and tyrosine residues is induced as a result of activation of CD3. The tyrosine phosphorylation is achieved via soluble tyrosine kinases belonging to the src family, p561ck and p59fyn. p59Jfn appears to be tightly associated with the T cell receptor [138] .
For B lymphocytes, a number of src-related kinases have been identified. These include p561ck and p53"n . The [141] . Since the tyrosine kinase inhibitor, genistein, can inhibit antigen-mediated PLC activation, it has been speculated that PLC-y is activated by a soluble tyrosine kinase [142] . A direct demonstration that oligomeric IgE induces tyrosine phosphorylation of PLC-y1 in RBL cells has been presented [143] .
Another potential regulator of tyrosine-phosphorylated PLCyl that is present in essentially all haematopoietic cells including T and B lymphocytes is CD45, a large (180-220 kDa) transmembrane tyrosine protein phosphatase [144] . Although no extracellular ligand has yet been identified for CD45, antibodies 1992 [184] to CD45 are inhibitory to activation of PLC via CD3 [145, 146] . Nonetheless, the presence of CD45 is essential for the T cell receptor to couple efficiently to the PLC [147] .
PHOTOTRANSDUCTION IN INVERTEBRATES
On the basis of both biochemical, physiological and genetic evidence, it has been proposed that the phototransduction cascade in invertebrate photoreceptors involves G-proteincoupled activation of PLC by light-activated rhodopsin [70, 148] . A Drosophila visual mutant, norpA (no receptor potential A), has been described which is defective in the phototransduction process. Although the retinal cells show almost normal levels of rhodopsin, they fail to respond to light stimulation. These norpA mutants show virtual absence of PLC in the head region [149, 150] .
The norpA gene has now been shown to encode a 1095-aminoacid phospholipase C with extensive sequence similarity to PLC-/ll [151] . The gene is expressed in great abundance in the retina.
A second gene encoding another phospholipase (plc-21) has also been identified. The plc-21 gene encodes two transcripts, the protein products having 1305 and 1312 amino acids which are similar in sequence to the norpA protein and to the mammalian PLC-f family [152] . From biochemical studies the phospholipase C encoded by the norpA gene is the major PLC in these cells whilst the PLCs encoded by the plc-21 gene are in the minority [153] .
An antibody to the norpA protein recognizes an eye-specific protein of 130 kDa that is present in wild type head extracts but not in norpA mutants. The protein is associated with membranes and can be extracted with high salt, a property shared by PLCfamily.
Since PLC-,81 is regulated by the G-proteins of the Gq family, it would be predicted that a homologue of the Gq family may also be responsible for stimulating the photoreceptor-specific PLC encoded by the norpA gene of Drososphila. The principal Gprotein in squid photoreceptor cells has been identified and is closely related to the Gq family of G-proteins. It is present at about 10 % the concentration of rhodopsin, a ratio similar to that found in the vertebrate photoreceptor [154] . This strongly suggests that in the invertebrate phototransduction system, a Gprotein which is homologous to the mammalian Gq regulates an invertebrate PLC which shares sequence similarity to the PLC-fl family. [165] .
AVIAN ERYTHROCYTES
A further feature that is emerging is that activation of one receptor can modulate the response of another receptor. In FRTL-5 (thyroid) cells, TSH has been shown to stimulate both adenylate cyclase as well as phospholipase C [162, 166] [167] . The simplest and economical explanation is that cAMPdependent phosphorylation attenuates the PLC activity. Adenosine, by blocking the rise in cyclic AMP, allows the PLC to respond normally. Cyclic AMP dampens the PLC response, presumably by phosphorylation of PLC, and therefore reduction in the cyclic AMP signal by adenosine removes this constraint. These interactions are summarized in Fig. 4 .
In the physiological environment, cells will be exposed to a multitude of agonists, and therefore, cellular signalling' by a single agonist will be dictated not only by its interaction with its own receptor but by the presence of other bioactive molecules. Parallel networks allow the cells to change output responses in a more sophisticated manner than is possible were cells to respond to agonists in a non-interactive manner.
A further twist to PLC signalling is the observation that signalling via different receptors all coupled to PLC can utilize different sets of G-proteins systems in the same cell type. Given that within a single cell there are likely to be a number of Gprotein-coupled receptors all signalling via phospholipase C, do they access a common pool of G-proteins and/or phospholipases? The current evidence is suggestive of different G-protein-coupled receptors interacting with only a subset of Gproteins. This is based on the observation that in many cell types, different receptors appear to stimulate phospholipase C in an additive fashion [168] [169] [170] [171] .
PATHOPHYSIOLOGY OF PHOSPHOLIPASES
Since the phospholipases C play such a prominent role in the activation of cellular function, it is not surprising that phospholipases may be involved in causing some of the pathophysiology. This is just beginning to be explored as our knowledge of the phospholipases and their regulation is expanding [172] [173] [174] . Microinjection of PLC-yl or PLC-fll has been shown to induce DNA synthesis in growth-arrested fibroblast cells [172] but inhibited when antibodies to PLC-yl are microinjected in serum-stimulated cells [173] . Since PLC-yl is a direct substrate for many growth factor receptors such as PDGF, EGF, NGF, it may provide signals for cell proliferation. It has been reported recently that the relative content of PLC-yl in primary mammary carcinomas is considerably higher in comparison to normal breast tissues [175] . Since over-expression of PLC-yl per se in 3T3 cells does not influence mitogenesis [174] , other factors such as receptor upregulation must also be important [175] . A member of the PLC-y family has also been purified from human melanomas [176] , implying that cell proliferation in cancer cells may be influenced by the higher levels of PLC-y.
Although the mechanism of regulation of the PLC-S family by receptors is unknown at the present time, it is likely that their activity is tightly regulated. In aorta cytosol, analysis of the phospholipases revealed the presence of only two phospholipases (PLC-yl and 41). In spontaneously hypertensive rats, the activity of PLC-61 is increased in the aorta compared with normal rats [177] . This increase in activity was not due to increased expression of the enzyme but was suggested to be due to a mutation. The abnormality may have resulted from point mutations in the X and Y regions of the enzyme [178] . Clearly, a further analysis of PLC-S at the genetic level from normal and hypertensive rats is called for to locate the lesion. Abnormal distribution of PLC-81 (but not PLC-,fl, -yl or y2) has also been shown to be associated with the formation of paired helical filaments in human brains of patients suffering from Alzheimer disease [179] . Knowledge of the regulation of PLC-8 family by receptors and its mechanism of regulation has to be the next major goal.
CONCLUSIONS AND FUTURE PERSPECTIVES
What has clearly emerged from studies to date is that regulation of PLC is far more complex in comparison to adenylate cyclase regulation. Two independent mechanisms of regulation have been identified, a G-protein-regulated pathway (Fig. 2) and a tyrosine-kinase-mediated pathway (Fig. 3) . The G-proteins involved in coupling the receptor to the phospholipases are just beginning to be defined and it is now fairly established that the newly identified Gq family of G-proteins regulate the PLC-,f family. A second isoform, PLC-e, is also regulated by an unidentified G-protein. PLC-yl and PLC-y2, on the other hand, are regulated by tyrosine kinase-mediated phosphorylation. Some receptors (e.g. the T-cell receptor) use soluble tyrosine kinases of the src family whilst other receptors (e.g. PDGF receptor) contain tyrosine kinase activity. This differential form of regulation is summarized in Figs. 2 and 3 .
What defines receptor-G-protein and G-protein-effector interactions? Answers to these questions will unravel some of the mysteries behind cellular signalling. Although more than 100 Gprotein receptors have been cloned [180] and as many as 17 heterotrimeric G-protein a-subunits [80] , we are still a long way from understanding what drives these interactions. A possibility that has emerged recently is that fly-subunits of G-proteins may also be regulators of PLCs [181] . Studies of these questions will require detailed investigation using not just purified components but also studies done in native membrane preparations. The molecular architecture of the environment may play an important role in mediating some of the specificity that is observed in cells. It is worth noting that fidelity of coupling is also lost when receptors are transfected into an unnatural environment [182] .
Just to provide a bit of spice to life, there appears to be some interaction between these two modes of PLC regulation. A prime example is the EGF receptor on hepatocytes. The EGF receptor is a tyrosine kinase and yet its activation of PLC can be blocked by pertussis toxin [48, 183] . The EGF receptor co-immunoprecipitates with a G, protein a subunit. Activation of the Fc receptor for IgG (FcyRII) has recently been shown to activate tyrosine phosphorylation of PLC-yl [184] and yet activation of this receptor can also be inhibited by pertussis toxin pretreatment [185, 186] . Obviously, there is ample room for innovative interactions in cellular signalling between G-proteins and tyrosine kinases.
Of the three known families of PLCs, fi, y and 8, regulation of PLC-,f and y is now beginning to be understood. However, there is no information regarding the regulation of the entire PLC-1 family although it is subject to intense scrutiny. This is clearly an important area since it may be involved in such diseases as hypertension.
Note added in proof
Berstein et al. [275] have recently reported that PLC-,f1
accelerates the receptor-stimulated GTPase activity of Gq. This result implies that PLC-f1 contains both GAP (GTPase-Activating Protein) activity as well as enzymic activity for hydrolysing PtdInsP2. The increased turn-off rate is more ideally suited to that required for regulating physiological processes in vivo.
Work in the authors' laboratory is supported by the MRC and the Wellcome Trust. It is a pleasure to thank Dr. S. G. Rhee for making preprints available.
